Thus, close monitoring is required before administering and during the treatment of this GLP-1
Side Effects, Tolerability, and Safety Considerations Both tirzepatide and semaglutide can cause gastrointestinal side effects including nausea, vomiting, constipation, and diarrhea, particularly during dose initiation or escalation
Other serious but less common risks include pancreatitis, gallbladder problems, kidney issues, and hypoglycemia when used with certain other diabetes medications
Nesheiwat explained.
How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments | Thursday, March 14, 2024 8am PST // 11am EST // 4pm GMT Peptidic GLP-1R agonists have received significant media coverage over the past year for their astounding efficacy in several indications
Wharton, the STEP 5 Study Group, Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial